Loading company details...
Beta
Latest Form 4 (Oct 2, 2026): Joshua Silverman (Executive Chairman): Grant/Award of 16,620 shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | Joshua Silverman, Executive Chairman | Grant/Award | 16,620 | n/a |
| Oct 2, 2026 | Joshua Silverman, Executive Chairman | Grant/Award | 16,806 | n/a |
| May 14, 2026 | Chelsea Sierra Voss | Purchase | 1,753 | $5.5K |
| Apr 15, 2026 | Stephen Friscia | Grant/Award | 50,000 | n/a |
| Apr 15, 2026 | Chelsea Sierra Voss | Grant/Award | 50,000 | n/a |
| Apr 15, 2026 | Mitchell Glass, Chief Medical Officer | Grant/Award | 50,000 | n/a |
| Apr 15, 2026 | Billy Joe White | Grant/Award | 50,000 | n/a |
| Apr 15, 2026 | Bruce Bernstein | Grant/Award | 50,000 | n/a |
| Jan 30, 2026 | Chelsea Sierra Voss | Grant/Award | 212,500 | n/a |
| Nov 18, 2025 | PharmaCyte Biotech, Inc. | Purchase | 889,865 | n/a |